Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

    Forecasted

    The FDA is funding a clinical trial to study the abuse potential of Kratom, a plant with opioid-like effects, requiring an IND application and IRB clearance.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

    This grant supports clinical trials and research to improve pain management, addiction treatment, anesthesia safety, and drug prescribing practices.

    HHS-FDA$2,000,000Forecasted

    Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

    Use existing data to analyze drug use behaviors, prevention strategies, and service utilization, aiming to advance substance use research.

    HHS-NIH11Due Dec 3, 2026· 17d$4,000,000

    Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

    Funds basic research on the harmful acute and delayed effects of ultra-potent synthetic opioids like fentanyl, including combinations, to develop countermeasures.

    HHS-NIH11Due Nov 18, 2026· 2d$1,500,000

    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

    Funding for research developing non-addictive pain treatments through early drug discovery to support the Pain Therapeutics Development Program.

    HHS-NIH11Due Dec 16, 2026$350,000

    Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

    This grant aims to identify drug and formulation factors causing alcohol-induced rapid release from modified-release drugs, improving testing and development for safer generics.

    HHS-FDA$250,000Forecasted